Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05480644 · ClinicalTrials.gov registry record
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
A clinical trial of Brain Metastases, Adult and Brain Tumor, Primary, sponsored by Duke University.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT05480644 is a study of Brain Metastases, Adult and Brain Tumor, Primary that is actively recruiting participants, run by Duke University. The registered enrollment target is 300 participants, above the 75-participant average among 14 other Brain Metastases, Adult trials with a reported enrollment target (300% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05480644, a study of Brain Metastases, Adult and Brain Tumor, Primary, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.
Conditions Studied
Study Locations (1)
North Carolina
- Duke Cancer Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2032-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05480644
The ClinicalTrials.gov registry entry for NCT05480644 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 75-participant average among 14 other Brain Metastases, Adult trials with a reported enrollment target (300% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Brain Metastases, Adult appearing as the primary indexed condition, and to 0 interventions.
NCT05480644 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05480644 about?
NCT05480644 is a clinical study titled "Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors". The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.
What is the current status of trial NCT05480644?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2022-12-01. Estimated completion is 2032-12.
What conditions does trial NCT05480644 study?
This clinical trial studies the following conditions: Brain Metastases, Adult, Brain Tumor, Primary.
Who is sponsoring clinical trial NCT05480644?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05480644 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Metastases, Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
RECRUITING · Phase 1
-
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
RECRUITING · Phase 1
-
Multi-disciplinary Care for Brain Metastases
RECRUITING · NA
-
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases
RECRUITING · Phase 2
-
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
RECRUITING · Phase 1
-
Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.